Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2
Cancer Letters · 2025-07 · 621 · 217583
DOI: 10.1016/j.canlet.2025.217583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-07. Verfasst von Ran Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Frontier Science Center for Stem Cell Research & Institute for Regenerative Medicine, Shanghai East Hos…. Hauptthemen laut MEDLINE: Hexokinase, Pancreatic Neoplasms, Glycolysis, Proto-Oncogene Proteins c-ret. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, Frontier Science Center for Stem Cell Research & Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, PR Chi…
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200025, PR China. Electronic address: yangludi_opth@163.com.
Zitieren
APA
Cui, R., Wang, G., Liu, F., Wang, Y., Zhao, Z., Mutailipu, M., Mu, H., Jiang, X., Le, W., Yang, L., & Chen, B. (2025). Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Cancer Letters, 621, 217583. https://doi.org/10.1016/j.canlet.2025.217583
Vancouver
Cui R, Wang G, Liu F, Wang Y, Zhao Z, Mutailipu M, et al. Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Cancer Letters. 2025;621:217583. doi:10.1016/j.canlet.2025.217583
BibTeX
@article{Cui2025,
author = {Cui, Ran and Wang, Gaoming and Liu, Fuguo and Wang, Yongkun and Zhao, Zinan and Mutailipu, Muladili and Mu, Huiling and Jiang, Xiaohua and Le, Wenjun and Yang, Ludi and Chen, Bo},
title = {Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2},
journal = {Cancer Letters},
year = {2025},
volume = {621},
pages = {217583},
doi = {10.1016/j.canlet.2025.217583}
}
EUVIMED